Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

17.28
+0.26001.53%
Post-market: 17.280.00000.00%19:30 EDT
Volume:957.41K
Turnover:16.63M
Market Cap:989.46M
PE:-20.70
High:17.71
Open:17.26
Low:17.00
Close:17.02
52wk High:18.14
52wk Low:1.54
Shares:57.26M
Float Shares:41.60M
Volume Ratio:0.62
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8347
EPS(LYR):-0.8974
ROE:-27.10%
ROA:-18.45%
PB:4.13
PE(LYR):-19.26

Loading ...

Climb Bio Inc - to Share Initial Phase 2 Data in Second Half of 2026

THOMSON REUTERS
·
Apr 07

Climb Bio Inc - Susan Altschuller to Serve as Principal Accounting Officer Effective April 30, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 04

Climb Bio SVP Finance Cindy Driscoll to exit; CFO Altschuller adds accounting role

Reuters
·
Apr 04

Climb Bio Initiated at Buy by B. Riley Securities

Dow Jones
·
Mar 24

Climb Bio Initiated at Buy by Truist Securities

Dow Jones
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18

Climb Bio Inc : Raymond James Initiates Coverage With Strong Buy Rating; Target Price $25

THOMSON REUTERS
·
Mar 11

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Reuters
·
Mar 11

Climb Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 10

Climb Bio price target raised to $15 from $11 at H.C. Wainwright

TIPRANKS
·
Mar 10

Climb Bio, Inc. : H.c. Wainwright Raises Target Price to $15 From $11

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Wedbush Raises Price Target on Climb Bio to $14 From $12, Keeps Outperform Rating

MT Newswires Live
·
Mar 06

Climb Bio price target raised to $12 from $9 at Baird

TIPRANKS
·
Mar 06

Climb Bio Initiated at Outperform by Wedbush

Dow Jones
·
Mar 05

Wedbush Initiates Climb Bio at Outperform With $12 Price Target

MT Newswires Live
·
Mar 05

Climb Bio Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $12.00

THOMSON REUTERS
·
Mar 05

Climb Bio Q4 EPS $(0.26) Misses $(0.18) Estimate

Benzinga Earnings
·
Mar 05

Climb Bio Inc - Qtrly EPS $-0.26

THOMSON REUTERS
·
Mar 05

Climb Bio Q4 R&D expenses rise to USD 13.7 million (+130.5%)

Reuters
·
Mar 05